Pharmaceuticals
Breast cancer screenings should start at age 40 instead of 50, U.S. panel says
Medical personnel use a mammogram to examine a woman’s breast for breast cancer. Hannibal Hanschke | dpa | Picture Alliance | Getty Images Most women should get screened for breast cancer every other year starting at age 40, a decade earlier than previously recommended, according to draft guidelines issued Tuesday by a government-backed panel of […]
Read More
Novavax shares rise after company unveils positive vaccine data, plan to cut 25% of workforce
A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague, Netherlands. Patrick Van Katwijk | Getty Images Shares of Novavax rose 5% in premarket trading Tuesday after the company unveiled promising new vaccine data and a […]
Read More
Kenvue CEO looks to brand, product innovation to drive growth after IPO
Thibaut Mongon, CEO of Kenvue Inc. a Johnson & Johnson consumer-health business, speaks during an interview with CNBC during his company’s IPO at the New York Stock Exchange (NYSE), May 4, 2023. Brendan McDermid | Reuters Kenvue CEO Thibaut Mongon is betting on brand and product innovation to drive growth at the newly spun-out company […]
Read More
Johnson & Johnson’s consumer health unit Kenvue started trading. What it means for J&J shareholders like us
Johnson & Johnson ‘s (JNJ) consumer-health unit Kenvue (KVUE) soared more than 22% on its first day of trading Thursday, bringing the Club holding one step closer to completing its business separation. The planned split, which is set for later this year, is in the best interest of shareholders of both the soon-to-be-solo Kenvue operations […]
Read More
J&J’s consumer health spinoff Kenvue opens at $25.53, a 16% jump, in public market debut
Thibaut Mongon, CEO and Paul Ruh CFO of Kenvue Inc. a Johnson & Johnson’s consumer-health business, pose together during the company’s IPO at the New York Stock Exchange (NYSE) in New York City, U.S., May 4, 2023. Brendan McDermid | Reuters Johnson & Johnson‘s consumer health spinoff Kenvue jumped 16% in its market debut on […]
Read More
Moderna posts surprise quarterly profit despite waning demand for Covid vaccines
Moderna’s sign is seen outside of their headquarters in Cambridge, MA on March 11, 2021. Boston Globe | Getty Images Moderna on Thursday blew past estimates for first-quarter earnings and revenue, posting a surprise quarterly profit, despite lower demand for Covid vaccines, its only marketable product. The biotech company generated first-quarter sales of $1.9 billion, […]
Read More
Novo Nordisk cuts some U.S. supply of Wegovy being overweight drug as demand soars
Danish pharmaceutical company Novo Nordisk said Thursday it was slicing the source of starter doses of its weight problems drug Wegovy in the U.S. as it struggles to preserve up with surging demand from customers. Main Economic Officer Karsten Munk Knudsen told CNBC that halving the provide of Wegovy starter doses was supposed to make certain present patients could […]
Read More
FDA approves GSK’s RSV vaccine for older adults, world’s first shot against virus
A GSK lab in London. Oli Scarff | Getty Images The Food and Drug Administration on Wednesday approved an RSV vaccine produced by GlaxoSmithKline for use on adults ages 60 and older. The approval, the first ever globally by a regulatory body for an RSV vaccine, is a decisive victory for GSK in a race […]
Read More
J&J’s consumer health business Kenvue is going public this week. Here’s what to know
Johnson & Johnson products on a shelf in a store in New York. Lucas Jackson | Reuters Johnson & Johnson‘s consumer health business, Kenvue, is expected to go public this week in the largest U.S. IPO in more than a year. That business is chock full of household names familiar to investors and the larger […]
Read More
Pfizer earnings and revenue top expectations despite Covid vaccine sales decline
Pharmaceutical Pfizer Inc. said that an oral drug for treating COVID-19 could be available by end of 2021. Soumyabrata Roy | NurPhoto | Getty Images Pfizer on Tuesday reported first-quarter revenue and adjusted earnings that topped Wall Street’s expectations, despite a decline in sales driven by the lower demand for the company’s Covid vaccine. Pfizer’s […]
Read More